Case Studies & Whitepapers2024-09-18
From R&D to Phase III: Peptide 39AA Project Completed in 10 Months
With strict project planning and implementation, the research and development of 45AA straight chain peptide was completed in 2 months, and the subsequent production and quality testing of non-GMP (300g) and GMP (1kg) batches were successfully completed in the following 8 months.
The maximum single impurity of the final product does not exceed 0.5%, and the total yield reaches 30%. All manufacturing and quality control are carried out in accordance with GMP requirements, ensuring the q
More
News
More
Case Studies & Whitepapers2026-02-28
The Perfect Integration of Immobilized Enzymes and Flow Chemistry: A Powerful Booster for the Commercialization of Biocatalysis Technology
Adhering to Porton’s core value of “Pursuing Excellence”, Porton biocatalysis team has designated "enzyme immobilization technology and its industrialization" as a core strategic technology.
Case Studies & Whitepapers2026-01-31
Process Simulation Platform: Enabling Process Development and Scale-up of Active Pharmaceutical Ingredients
Porton Crystallization team has the capability to perform process simulation of unit operations, including solvent swap, crystallization, filtration and drying.
